Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status

(2020) Basile Tessier-Cloutier et al.   MODERN PATHOLOGY

Intratumour heterogeneity of p53 expression; causes and consequences

(2019) Yuezhen Xue et al.   JOURNAL OF PATHOLOGY

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases

(2019) Nicola S. Meagher et al.   MODERN PATHOLOGY

The molecular origin and taxonomy of mucinous ovarian carcinoma

(2019) Dane Cheasley et al.   Nature Communications

p53 immunohistochemistry is an accurate surrogate for TP53 mutational analysis in endometrial carcinoma biopsies

(2019) Naveena Singh et al.   JOURNAL OF PATHOLOGY

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas

(2018) Martin Köbel et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

(2015) Robertson Mackenzie et al.   BMC CANCER

A Patient With a Noninvasive Mucinous Ovarian Borderline Tumor Presenting With Late Pleural Metastases

(2015) Michiel Simons et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors

(2015) Georgina L. Ryland et al.   Genome Medicine

ClinVar: public archive of relationships among sequence variation and human phenotype

(2013) Melissa J. Landrum et al.   NUCLEIC ACIDS RESEARCH

Pre-Invasive Ovarian Mucinous Tumors Are Characterized by CDKN2A and RAS Pathway Aberrations

(2012) S. M. Hunter et al.   CLINICAL CANCER RESEARCH

Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma

(2011) Linda E Kelemen et al.   LANCET ONCOLOGY

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

(2010) Ahmed Ashour Ahmed et al.   JOURNAL OF PATHOLOGY